首页> 外文期刊>British journal of clinical pharmacology >Scotland's 2009–2015 methadone‐prescription cohort: Quintiles for daily dose of prescribed methadone and risk of methadone‐specific death
【24h】

Scotland's 2009–2015 methadone‐prescription cohort: Quintiles for daily dose of prescribed methadone and risk of methadone‐specific death

机译:苏格兰的2009-2015美沙酮 - 处方队列:每日服用美沙酮的日常剂量和美沙酮特异性死亡风险

获取原文
           

摘要

Aims As methadone clients age, their drug‐related death (DRD) risks increase, more than doubling at 45 years for methadone‐specific DRDs. Methods Using Community Health Index (CHI) numbers, mortality to 31 December 2015 was ascertained for 36 347 methadone‐prescription clients in Scotland during 2009–2015. Cohort entry, quantity of prescribed methadone and daily dose (actual or recovered by effective, simple rules) were defined by clients' first CHI‐identified methadone prescription after 30 June 2009 and used in proportional hazards analysis. As custodian of death records, National Records of Scotland identified non‐DRDs from DRDs. Methadone‐specific DRD means methadone was implicated but neither heroin nor buprenorphine. Results The cohort's 192 928 person‐years included 1857 non‐DRDs and 1323 DRDs (42%), 546 of which were methadone specific. Actual/recovered daily dose was available for 26 533 (73%) clients who experienced 420 methadone‐specific DRDs. Top quintile for daily dose at first CHI‐identified methadone prescription was 90 mg. Age 45 years at cohort‐entry (hazard ratio vs 25–34 years: 3.1, 95% confidence interval: 2.4–4.2), top quintile for baseline daily dose of prescribed methadone ( vs 50–70 mg: 1.9, 1.1–3.1) and being female (1.3, 1.0–1.6) significantly increased clients' risk of methadone‐specific DRD. Conclusion Extra care is needed when methadone daily dose exceeds 90 mg. Females' higher risk for methadone‐specific DRD is new and needs validation. Further analyses of prescribed daily dose linked to mortality for large cohorts of methadone clients are needed internationally, together with greater pharmacodynamic and pharmacokinetic understanding of methadone by age and sex. Balancing age‐related risks is challenging for prescribers who manage chronic opiate dependency against additional uncertainty about the nature, strength and pharmacological characteristics of drugs from illegal markets.
机译:旨在作为美沙酮的客户年龄,他们的毒品相关死亡(DRD)风险增加,45岁的含量增加了45岁的含量。方法使用社区健康指数(CHI)数量,2015年12月31日的死亡率为2009 - 2015年在苏格兰的36个347美沙酮 - 处方客户确定。队列进入,规定美沙酮的数量和每日剂量(通过有效,简单的规则实际或恢复)由客户在2009年6月30日之后的第一个Chi鉴定的美沙酮处方定义,并用于比例危害分析。作为死亡记录的托管人,苏格兰的国家记录发现了来自DRDS的非DRD。特定于美沙酮的DRD意味着美沙酮涉及,但既不是海洛因也不是丁丙诺啡因。结果COHORT的192 928人组包括1857名非干旱和1323个DRDS(42%),其中546个是美沙酮特异性的。实际/回收的日剂量可获得26 533(73%)的客户,他们经历了420个美沙酮的DRD。在第一个CHI鉴定的美沙酮处方的每日剂量的顶级含量& 90毫克。 45年龄在群组进入(危险比率与25-34岁以下):3.1,95%置信区间:2.4-4.2),基线每日剂量的顶级含有规定的美沙酮(VS 50-70 mg:1.9,1-3.1)作为女性(1.3,1-1.6)显着提高了客户对美沙酮特定DRD的风险。结论美沙酮日剂量超过90毫克,需要额外保健。女性对美沙酮特异性DRD的风险较高是新的,需要验证。进一步分析与大规模群体的死亡率相关的每日剂量与甲基客户的大群体相连,并通过年龄和性别改善对美沙酮的更大的药效学和药代动力学理解。平衡年龄相关的风险是针对管理慢性表现依赖的公务员对非法市场的性质,实力和药理特征的额外不确定性的规定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号